MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Motor control"

  • 2022 International Congress

    The impact of thyroid disease on severity of motor symptoms in Croatian residents with de novo Parkinson’s disease

    I. Sarac, H. Sarac, F. Borovecki, I. Ivek, L. Bagaric Krakan, Z. Kresic, M. Iveta, T. Sukobljevic (Zagreb, Croatia)

    Objective: The goal of this study was to investigate the association between thyroid disease and severity of motor symptoms in Croatian residents with de novo…
  • 2022 International Congress

    Motor decision-making in Parkinson’s disease

    L. Avanzino, B. Berret, E. Pelosin, M. Bove, T. Pozzo, A. Bisio (Genoa, Italy)

    Objective: The aim of this study is to test motor decision-making ability in Parkinson's disease (PD) in conditions with different biomechanical properties and levels of…
  • 2022 International Congress

    Detecting Parkinson’s Disease from body limb acceleration using machine learning and a frequency-domain analysis

    C. Cermeño-Silveira, JI. Godino-Llorente, A. Muñoz-Gonzalez, J. Perez-Sanchez, M. Gonzalez-Sanchez, F. Grandas-Perez, D. Torricelli (Madrid, Spain)

    Objective: To test whether the acceleration frequency of different body parts during gait can reveal characteristic patterns of Parkinson’s Disease (PD). The technical aim was…
  • 2022 International Congress

    Effect of KW-6356, a novel adenosine A2A receptor antagonist/inverse agonist, on motor and non-motor symptoms in Parkinson’s disease patients as an adjunct to levodopa therapy: Results of Phase 2b study

    T. Maeda, K. Sugiyama, K. Yamada, M. Nishi, N. Hattori (Iwate, Japan)

    Objective: To evaluate the efficacy and safety of KW-6356 in Parkinson’s disease (PD) patients with levodopa therapy, irrespective of the presence of wearing-off (WO). Background:…
  • 2022 International Congress

    Dopaminergic modulation of express reaching responses in Parkinson’s disease

    M. Gilchrist, R. Kozak, B. Corneil, P. Macdonald (London, Canada)

    Objective: This study investigates the role of dopamine (DA) in modulation of automatic stimulus-driven responses. We investigated the effect of PD, DA medication, and instruction…
  • 2022 International Congress

    Task-Specific Dystonia is a predominant disorder of Top-Down Sensorimotor integration

    S. Merchant, M. Hallett (Boston, USA)

    Objective: In this study we investigate two neurophysiologic variables testing for central-peripheral and peripheral-central mechanisms of SM integration in a cohort of TSD to evaluate…
  • 2022 International Congress

    PP1α negatively regulates D2 receptor mediated cadmium induced motor dysfunctions: protective potential of Quercetin.

    R. Gupta, R. Shukla, V K. Khanna (LUCKNOW, India)

    Objective: The present study has been focused to identify the molecular targets that involved in Cadmium-induced motor dysfunctions. At the same time, we also focused…
  • 2022 International Congress

    Mindfulness based program for newly diagnosed Parkinson’s patients.

    A. Shaji, A. Lasker, N. Ko, M. Solanki, P. Kaur, Y. Ocasio, C. Fanning (Bethlehem, USA)

    Objective: To investigate the impact of 8-week course of Mindfulness based intervention program on motor and or non-motor symptoms of PD assessed by improvement in…
  • 2022 International Congress

    Binaural acoustic stimulation reduces tremor severity in patients suffering from Parkinson’s disease

    A. Calvano, L. Timmermann, C. Oehrn, I. Weber (Marburg, Germany)

    Objective: To assess the effects of BBS on motor symptoms in PD. Background: Acoustic stimulation (AS) can improve motor symptoms in Parkinson’s disease (PD) and…
  • 2022 International Congress

    Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature

    L. Hickman, D. Fraser, J. Galea, J. Cook (Birmingham, United Kingdom)

    Objective: This study assessed kinematic profiles of individuals with Parkinson’s on and off dopaminergic medication to investigate whether the effect of dopaminergic modulation on speed…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 40
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley